The only variable that resulted to have differences in distribution among all patients included in the analysis was the presence of lymphovascular invasion in the tumor, which resulted to be more frequently observed in KRAS G12V and other mutations different from either G12C or G12D (p=0.004). The gene discussed is KRAS; the disease is neoplasm.